Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Army
Baxter
Deloitte
Julphar
Accenture

Generated: March 18, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: TACROLIMUS

« Back to Dashboard

TACROLIMUS

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Astellas ASTAGRAF XL tacrolimus CAPSULE, EXTENDED RELEASE;ORAL 204096 NDA Astellas Pharma US, Inc. 0469-0647-11 5 BLISTER PACK in 1 CARTON (0469-0647-11) > 10 CAPSULE, COATED, EXTENDED RELEASE in 1 BLISTER PACK
Astellas ASTAGRAF XL tacrolimus CAPSULE, EXTENDED RELEASE;ORAL 204096 NDA Astellas Pharma US, Inc. 0469-0647-73 1 BOTTLE in 1 CARTON (0469-0647-73) > 30 CAPSULE, COATED, EXTENDED RELEASE in 1 BOTTLE
Astellas ASTAGRAF XL tacrolimus CAPSULE, EXTENDED RELEASE;ORAL 204096 NDA Astellas Pharma US, Inc. 0469-0677-11 5 BLISTER PACK in 1 CARTON (0469-0677-11) > 10 CAPSULE, COATED, EXTENDED RELEASE in 1 BLISTER PACK
Astellas ASTAGRAF XL tacrolimus CAPSULE, EXTENDED RELEASE;ORAL 204096 NDA Astellas Pharma US, Inc. 0469-0677-73 1 BOTTLE in 1 CARTON (0469-0677-73) > 30 CAPSULE, COATED, EXTENDED RELEASE in 1 BOTTLE
Astellas ASTAGRAF XL tacrolimus CAPSULE, EXTENDED RELEASE;ORAL 204096 NDA Astellas Pharma US, Inc. 0469-0687-11 5 BLISTER PACK in 1 CARTON (0469-0687-11) > 10 CAPSULE, COATED, EXTENDED RELEASE in 1 BLISTER PACK
Astellas ASTAGRAF XL tacrolimus CAPSULE, EXTENDED RELEASE;ORAL 204096 NDA Astellas Pharma US, Inc. 0469-0687-73 1 BOTTLE in 1 CARTON (0469-0687-73) > 30 CAPSULE, COATED, EXTENDED RELEASE in 1 BOTTLE
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Teva
QuintilesIMS
Boehringer Ingelheim
Moodys
Julphar